跳至主要内容
临床试验/NCT05793632
NCT05793632已完成2 期

Role of Quetiapine in the Prevention of ICU Delirium in Elderly Patients at a High Risk

Ain Shams University1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2023年3月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
90
试验地点
1
主要终点
Quetiapine in preventing delirium

研究概览

简要总结

The aim is to study the effectiveness of Quetiapine in preventing delirium in the elderly patients with multiple risks for delirium.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Participant, Investigator)

入排标准

年龄范围
60 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with anemia
  • Sedated patients
  • Hypotensive patients
  • Immobilized patients
  • Patients with visual or auditory impairment

排除标准

  • Patients or guardians refuse to participate
  • Patients diagnosed with delirium
  • Contraindication for delirium

研究组 & 干预措施

Quetiapine

Experimental

The patients with multiple risks for delirium will receive 25 mg/day PO

干预措施: Quetiapine (Drug)

结局指标

主要结局

Quetiapine in preventing delirium

时间窗: 2 months

The presence of delirium will be monitored among the patients in the two groups using ICU-Confusion Assessment Method 7 score for delirium where a score of (0-2 = no delirium, 3-5 = mild to moderate delirium and a score \>5 = severe delirium)

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验